Literature DB >> 6845264

Slope of the dose-response curve: usefulness in assessing bronchial responses to inhaled histamine.

D W Cockcroft, B A Berscheid.   

Abstract

The value of determining the slope of the histamine dose-response curve, in addition to the histamine provocation concentration producing a 20% reduction in FEV1 (PC20-FEV1), was assessed by analysis of histamine dose-response curves in 40 patients selected as having a wide range of increased non-specific bronchial responsiveness to inhaled histamine. The histamine dose-response curves were found to be fit the linear curve (dose v response, mean r2 = 0.97) better than the logarithmic curve (log dose v response, mean r2 = 0.93), the difference being significant (p less than 0.001). There was a strong negative correlation between the PC20-Fev1 and the slope (r = -0.98, p much less than 0.001) and a weak negative correlation between the PC20-FEV1 and the log-dose-response slope (r = -0.38, p greater than 0.05). Sixteen normal subjects and 16 asthmatic patients were compared on the basis of histamine dose-response curves measuring fal in sGaw. In this study there was no difference between r2 for the linear determination and for the logarithmic determination (0.91 v 0.90, p less than 0.05). The PC35-sGaw showed a strong negative correlation with the dose-response slope (r = -0.95, p much less than 0.01) and no correlation with the log-dose-response slope (r = 0.09, p greater than 0.05). In the two studies there appeared to be little information gained from the determination of either the dose-response slope or the log-dose-response slope. The slope and the PC20-FEV1 were equally reproducible, duplicate determinations showing less than a two-fold difference in 14 of 15 paired PC20 measurements and in 13 of 15 paired slope measurements. In summary, the slope of the histamine dose-response curve appears to fit the linear model better than the logarithmic model. It is feasible to calculate it from the results of a standardised histamine inhalation test; determination of either the slope or the log-dose-response slope, however, appears to add little useful information. It is recommended that bronchial provocation test results should be expressed in terms of a threshold concentration such as the PC20-FEV1 or the PC35-sGaw.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6845264      PMCID: PMC459485          DOI: 10.1136/thx.38.1.55

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  10 in total

1.  Protective effect of drugs on histamine-induced asthma.

Authors:  D W Cockcroft; D N Killian; J J Mellon; F E Hargreave
Journal:  Thorax       Date:  1977-08       Impact factor: 9.139

2.  Bronchial reactivity to inhaled histamine: a method and clinical survey.

Authors:  D W Cockcroft; D N Killian; J J Mellon; F E Hargreave
Journal:  Clin Allergy       Date:  1977-05

3.  Airway response to carbachol in normal and asthmatic subjects: distinction between bronchial sensitivity and reactivity.

Authors:  J Orehek; P Gayrard; A P Smith; C Grimaud; J Charpin
Journal:  Am Rev Respir Dis       Date:  1977-06

4.  Studies with the quantitative-inhalation challenge technique. I. Curve of dose response to acetyl-beta-methylcholine in patients with asthma of known and unknown origin, hay fever subjects, and nonatopic volunteers.

Authors:  A B Felarca; I H Itkin
Journal:  J Allergy       Date:  1966-04

Review 5.  [Non-specific bronchial provocation tests in asthma (author's transl)].

Authors:  J Orehek; P Gayrard
Journal:  Bull Eur Physiopathol Respir       Date:  1976 Jul-Aug

Review 6.  Bronchial hyperreactivity.

Authors:  H A Boushey; M J Holtzman; J R Sheller; J A Nadel
Journal:  Am Rev Respir Dis       Date:  1980-02

7.  Standardization of inhalation provocation tests: two techniques of aerosol generation and inhalation compared.

Authors:  G Ryan; M B Dolovich; R S Roberts; P A Frith; E F Juniper; F E Hargreave; M T Newhouse
Journal:  Am Rev Respir Dis       Date:  1981-02

8.  Increased nonspecific bronchial reactivity in cigarette smokers with normal lung function.

Authors:  J W Gerrard; D W Cockcroft; J T Mink; D J Cotton; R Poonawala; J A Dosman
Journal:  Am Rev Respir Dis       Date:  1980-10

9.  Standardization of inhalation provocation tests: influence of nebulizer output, particle size, and method of inhalation.

Authors:  G Ryan; M B Dolovich; G Obminski; D W Cockcroft; E Juniper; F E Hargreave; M T Newhouse
Journal:  J Allergy Clin Immunol       Date:  1981-02       Impact factor: 10.793

10.  Reproducibility and comparison of responses to inhaled histamine and methacholine.

Authors:  E F Juniper; P A Frith; C Dunnett; D W Cockcroft; F E Hargreave
Journal:  Thorax       Date:  1978-12       Impact factor: 9.139

  10 in total
  8 in total

Review 1.  Methodology of bronchial responsiveness.

Authors:  S Chinn
Journal:  Thorax       Date:  1998-11       Impact factor: 9.139

Review 2.  Bronchial provocation tests with pharmacological agents.

Authors:  C B Robinson; G H Parsons
Journal:  Clin Rev Allergy       Date:  1990 Summer-Fall

3.  Analysis of bronchial reactivity in epidemiological studies.

Authors:  M J Abramson; N A Saunders; M J Hensley
Journal:  Thorax       Date:  1990-12       Impact factor: 9.139

Review 4.  Bronchial challenges.

Authors:  H Chai
Journal:  Clin Rev Allergy       Date:  1988

Review 5.  Measurement of bronchial responsiveness.

Authors:  C J Trigg; R J Davies
Journal:  Clin Rev Allergy       Date:  1989

6.  Bronchial reactivity and dietary antioxidants.

Authors:  A Soutar; A Seaton; K Brown
Journal:  Thorax       Date:  1997-02       Impact factor: 9.139

7.  Stepwise health surveillance for bronchial irritability syndrome in workers at risk of occupational respiratory disease.

Authors:  W K Post; K M Venables; D Ross; P Cullinan; D Heederik; A Burdorf
Journal:  Occup Environ Med       Date:  1998-02       Impact factor: 4.402

8.  Bisphenol A exposure and asthma development in school-age children: a longitudinal study.

Authors:  Kyoung-Nam Kim; Jin Hee Kim; Ho-Jang Kwon; Soo-Jong Hong; Byoung-Ju Kim; So-Yeon Lee; Yun-Chul Hong; Sanghyuk Bae
Journal:  PLoS One       Date:  2014-10-30       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.